AMS´ comprehensive Clinical Research
Indication Experience:

 

    • Immunology
    • Oncology / Hematology
    • Neurology
    • Rheumatology
    • CNS
    • Endocrinology
    • Cardiology
    • Respiratory
    • Nephrology
    • Gastrointestinal
    • Infectious Disease / Vaccines
    • Dermatology
    • Ophthalmology
    • Pediatrics
    • Rare Diseases

• 2022 – AMS are CTR- and MDR ready • 2022 – New unique AMS-ePRO® features launched • 2022 – Real-World Evidence focus in AMS Late-Stage Research • 2022 – AMS expanded its global reach • 2021 – DIGA dossier submission pioneer •

News